Sonoma Pharmaceuticals Inc logo

Sonoma Pharmaceuticals Inc

NAS:SNOA (USA)  
$ 0.14 +0.0017 (+1.24%) 11:08 PM EST
At Loss
P/B:
0.28
Enterprise V:
$ 195.00K
Volume:
280.00K
Avg Vol (2M):
1.85M
Also Trade In:
Volume:
280.00K
At Loss
Avg Vol (2M):
1.85M

Business Description

Description
Sonoma Pharmaceuticals Inc is a specialty pharmaceutical company operating in the United States. It is engaged in identifying, developing, and commercializing differentiated therapies for patients living with chronic skin conditions. The company focuses on the development and commercialization of therapeutic solutions in medical dermatology to treat skin conditions, such as acne, atopic dermatitis, and scarring. The key products of the company are Celacyn, Ceramax Skin Barrier Cream, Mondoxyne, Alevicyn, SebuDerm, Microcyn, and Microcyn which are available for various skin treatments such as scars, itchy skin, minor skin irritations, rashes, and others. The company derives revenue from the sale of products in the United States, Latin America, Europe, and other countries.
Name Current Vs Industry Vs History
Cash-To-Debt 6.25
Equity-to-Asset 0.46
Debt-to-Equity 0.06
Debt-to-EBITDA -0.09
Interest Coverage N/A
N/A
N/A
Piotroski F-Score 5/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score -17.88
Distress
Grey
Safe
Beneish M-Score -2.12
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 37.55
9-Day RSI 38.44
14-Day RSI 40.15
6-1 Month Momentum % -82.53
12-1 Month Momentum % -84.86

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 4.07
Quick Ratio 3.11
Cash Ratio 0.78
Days Inventory 130.27
Days Sales Outstanding 73.58
Days Payable 47.63

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -40.5
Shareholder Yield % -52.07

Financials (Next Earnings Date:2024-05-31 Est.)

SNOA's 30-Y Financials
Income Statement Breakdown
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:SNOA

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Sonoma Pharmaceuticals Inc Executives

Details

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 12.31
EPS (TTM) ($) -0.94
Beta 2.01
Volatility % 83.66
14-Day RSI 40.15
14-Day ATR ($) 0.015687
20-Day SMA ($) 0.14826
12-1 Month Momentum % -84.86
52-Week Range ($) 0.1159 - 1.52
Shares Outstanding (Mil) 15.61

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 5
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Sonoma Pharmaceuticals Inc Filings

Filing Date Document Date Form
No Filing Data

Sonoma Pharmaceuticals Inc Stock Events

Financials Calendars
Event Date Price($)
No Event Data

Sonoma Pharmaceuticals Inc Frequently Asked Questions

What is Sonoma Pharmaceuticals Inc(SNOA)'s stock price today?
The current price of SNOA is $0.14. The 52 week high of SNOA is $1.52 and 52 week low is $0.12.
When is next earnings date of Sonoma Pharmaceuticals Inc(SNOA)?
The next earnings date of Sonoma Pharmaceuticals Inc(SNOA) is 2024-05-31 Est..
Does Sonoma Pharmaceuticals Inc(SNOA) pay dividends? If so, how much?
Sonoma Pharmaceuticals Inc(SNOA) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1